Skip to main content
eScholarship
Open Access Publications from the University of California

Sugammadex vs Neostigmine: Possible Decrease in PACU Stay

The data associated with this publication are not available for this reason: N/A
Abstract

• Neostigmine – longstanding only choice for reversal of neuromuscular blockade

• Incomplete reversal and residual neuromuscular blockade: atelectasis, pulmonary edema, desaturations, postoperative pulmonary complications, and longer hospital stay

• March 2016: sugammadex introduced at UCDMC

• Sugammadex can rapidly reverse even deep neuromuscular blockade and is associated with fewer adverse events: decreased surgery duration, PACU stay, and overall hospital stay2

• This study aims to compare patient flow -neostigmine versus sugammadex end of surgery to PACU total PACU stay

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View